BMS-536924 (CS0117; BMS 536924)

Alias: BMS 536924; CS-0117; BMS536924; BMS-536924; CS0117; CS 0117
Cat No.:V0625 Purity: ≥98%
BMS-536924 (also called CS-0117; BMS536924; CS0117) is a novel, potent and ATP-competitivesmall molecule inhibitor of IGF-1R/IR with potential anticancer activity.
BMS-536924 (CS0117; BMS 536924) Chemical Structure CAS No.: 468740-43-4
Product category: IFG-1R
This product is for research use only, not for human use. We do not sell to patients.
Size Price Stock Qty
1mg
5mg
10mg
25mg
50mg
100mg
250mg
Other Sizes
Official Supplier of:
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text

 

  • Business Relationship with 5000+ Clients Globally
  • Major Universities, Research Institutions, Biotech & Pharma
  • Citations by Top Journals: Nature, Cell, Science, etc.
Top Publications Citing lnvivochem Products
Purity & Quality Control Documentation

Purity: ≥98%

Product Description

BMS-536924 (also called CS-0117; BMS536924; CS0117) is a novel, potent and ATP-competitive small molecule inhibitor of IGF-1R/IR with potential anticancer activity. With an IC50 of 100 nM/73 nM, it inhibits IGF-1R/IR. While BMS-536924 exhibited very little activity for Akt1, MAPK1/2, it did show modest activity against Mek, Fak, and Lck. In a number of tumor models, including the sarcoma and IGR-1R Sal tumor model, BMS-536924 demonstrates strong antitumor activity.

Biological Activity I Assay Protocols (From Reference)
Targets
Insulin Receptor (IC50 = 73 nM); IGF-1R (IC50 = 100 nM); FAK (IC50 = 150 nM); MEK (IC50 = 182 nM); LCK (IC50 = 341 nM)
ln Vitro
BMS-536924 also inhibits Lck and FAK, with IC50 values of 341 nM and 150 nM, respectively. BMS-536924 disrupts Akt and MAPK phosphorylation and inhibits the proliferation of cells. (Source: ) BMS-536924 inhibits constitutive IGF-1R activity in CD8-IGF-1R-MCF10A and suppresses IGF-I-stimulated IGF-1R signaling in MCF10A cells. The ability of IGF-I to stimulate IGF-1R phosphorylation is completely blocked when 1 μM BMS-536924 is preincubated with MCF10A cells. Increased phosphorylation of ERK1/2, GSK3β, and Akt is the outcome of IGF-I stimulation. BMS-536924 prevents this phosphorylation that is triggered by the ligand. BMS-536924 treatment of the CD8-IGF-1R-MCF10A cells inhibits phosphorylation in a dose-dependent manner, showing partial inhibition at 0.01 μM and 0.1 μM but complete receptor inhibition at 1 μM. As early as 10 minutes after incubation, the maximum inhibition of phosphorylated IGF-1R is seen. For as long as 48 hours, BMS-536924 can still prevent IGF-1R phosphorylation. After one hour, BMS-536924 is added, and this inhibits Akt phosphorylation in a time-dependent manner. After 48 hours, Akt activation is totally inhibited.[2] BMS-536924 treatment exhibits antiproliferation activity against a range of cancer cell lines, including CTR, HT1080/S, TC32, SK-LMS-1, and H513 cells. In Rh41 and Rh36 cell lines, pIGF-1R/pIR is activated in response to IGF-I/insulin stimulation, and the activation is blocked by BMS-536924 at comparable potencies. In Rh41 cells treated with BMS-536924, there is an up-regulation of the expression of caspase-3, cleavage of poly(ADP-ribose) polymerase (PARP), and programmed cell death 4 (PDCD4).[3]
ln Vivo
BMS-536924 administered orally at 100–300 mpk significantly inhibits the IGR-1R Sal tumor model. The non-engineered Colo205 human colon carcinoma mode also demonstrates efficacy. In this tumor model, oral administration of 3 on a once daily schedule (100-300 mpk) or twice daily schedule (50, 100 mpk) exhibits antitumor activity. The oral glucose tolerance test (OGTT) demonstrates that following a glucose challenge, 100 mpk (b.i.d.) significantly raises blood glucose levels. The oral administration of BMS-536924 in a solution of poly(ethylene glycol) 400 and water (80:20 v/v) was used to determine the pharmacokinetic parameters in mice, rats, dogs, and monkeys. In all species, good bioavailability is apparent. In rodents, significant nonlinear pharmacokinetics are seen with increasing PO dosage. [1] After two weeks of treatment (100 mg/kg), BMS-536924 reduces the volume of CD8-IGF-1R-MCF10A cells in tumor xenografts to 76%.[2] When given orally to nude mice, 70 mg/kg of BMS-536924 significantly suppresses the growth of tumors (TGBC-1TKB cells) that have been injected. The xenograft tumors' apoptosis is upregulated by BMS-536924. The mice's body weight and blood glucose levels at the moment of death show no negative effects from the treatment, indicating tolerable toxicity.[4]
Enzyme Assay
106 × 1 p On 60-mm dishes, Babe-MCF10A cells are seeded. The medium is switched to serum-free medium after the first 24 hours, and it is then incubated for an additional 24 hours at 37 °C. The cells are then stimulated with IGF-I (50 ng/mL) for 10 minutes after being pre-incubated for 1 hour in serum-free medium with or without 1 uM BMS-536924. After two PBS washes, cell monolayers are collected for immunoblot analysis.
Cell Assay
After being exposed to BMS-536924 for 72 hours, the incorporation of [3H]thymidine is used to assess cell proliferation. Following an overnight incubation period at 37 °C, cells are plated at an optimal density in 96-well plates and subjected to a series of drug dilutions. After a 72-hours incubation, cells are pulsed with 4 μCi/mL [3H]thymidine for 3 hours, trypsinized, harvested onto UniFilter-96 GF/B plates; scintillation is measured on a TopCount NXT. The IC50 represents the results. For every cell line, the mean IC50 and SD from several tests are computed.
Animal Protocol
TGBC-1TKB cells are subcutaneously injected into nude mice.
70 mg/kg
Oral once daily for 2 weeks
References

[1]. J Med Chem . 2005 Sep 8;48(18):5639-43.

[2]. Clin Cancer Res . 2009 Jan 1;15(1):226-37.

[3]. Cancer Res . 2009 Jan 1;69(1):161-70.

[4]. Cancer Sci . 2012 Feb;103(2):252-61.

[5]. Sci Signal . 2008 Sep 2;1(35):re9.

[6]. Cancer Res . 2009 Jan 1;69(1):161-70.

These protocols are for reference only. InvivoChem does not independently validate these methods.
Physicochemical Properties
Molecular Formula
C25H26CLN5O3
Molecular Weight
479.96
Exact Mass
479.17
Elemental Analysis
C, 62.56; H, 5.46; Cl, 7.39; N, 14.59; O, 10.00
CAS #
468740-43-4
Appearance
Solid powder
SMILES
CC1=CC(=CC2=C1N=C(N2)C3=C(C=CNC3=O)NC[C@H](C4=CC(=CC=C4)Cl)O)N5CCOCC5
InChi Key
ZWVZORIKUNOTCS-OAQYLSRUSA-N
InChi Code
InChI=1S/C25H26ClN5O3/c1-15-11-18(31-7-9-34-10-8-31)13-20-23(15)30-24(29-20)22-19(5-6-27-25(22)33)28-14-21(32)16-3-2-4-17(26)12-16/h2-6,11-13,21,32H,7-10,14H2,1H3,(H,29,30)(H2,27,28,33)/t21-/m1/s1
Chemical Name
4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-(4-methyl-6-morpholin-4-yl-1H-benzimidazol-2-yl)-1H-pyridin-2-one
Synonyms
BMS 536924; CS-0117; BMS536924; BMS-536924; CS0117; CS 0117
HS Tariff Code
2934.99.9001
Storage

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

Shipping Condition
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
Solubility Data
Solubility (In Vitro)
DMSO: ~96 mg/mL (~200.0 mM)
Water: <1 mg/mL
Ethanol: <1 mg/mL
Solubility (In Vivo)
30% PEG400+0.5% Tween80+5% propylene glycol: 30 mg/mL
 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.0835 mL 10.4175 mL 20.8351 mL
5 mM 0.4167 mL 2.0835 mL 4.1670 mL
10 mM 0.2084 mL 1.0418 mL 2.0835 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.

Calculator

Molarity Calculator allows you to calculate the mass, volume, and/or concentration required for a solution, as detailed below:

  • Calculate the Mass of a compound required to prepare a solution of known volume and concentration
  • Calculate the Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Calculate the Concentration of a solution resulting from a known mass of compound in a specific volume
An example of molarity calculation using the molarity calculator is shown below:
What is the mass of compound required to make a 10 mM stock solution in 5 ml of DMSO given that the molecular weight of the compound is 350.26 g/mol?
  • Enter 350.26 in the Molecular Weight (MW) box
  • Enter 10 in the Concentration box and choose the correct unit (mM)
  • Enter 5 in the Volume box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 17.513 mg appears in the Mass box. In a similar way, you may calculate the volume and concentration.

Dilution Calculator allows you to calculate how to dilute a stock solution of known concentrations. For example, you may Enter C1, C2 & V2 to calculate V1, as detailed below:

What volume of a given 10 mM stock solution is required to make 25 ml of a 25 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=25 μM, V2=25 ml and V1 is the unknown:
  • Enter 10 into the Concentration (Start) box and choose the correct unit (mM)
  • Enter 25 into the Concentration (End) box and select the correct unit (mM)
  • Enter 25 into the Volume (End) box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 62.5 μL (0.1 ml) appears in the Volume (Start) box
g/mol

Molecular Weight Calculator allows you to calculate the molar mass and elemental composition of a compound, as detailed below:

Note: Chemical formula is case sensitive: C12H18N3O4  c12h18n3o4
Instructions to calculate molar mass (molecular weight) of a chemical compound:
  • To calculate molar mass of a chemical compound, please enter the chemical/molecular formula and click the “Calculate’ button.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
  • Molecular mass (or molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
  • Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
/

Reconstitution Calculator allows you to calculate the volume of solvent required to reconstitute your vial.

  • Enter the mass of the reagent and the desired reconstitution concentration as well as the correct units
  • Click the “Calculate” button
  • The answer appears in the Volume (to add to vial) box
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal to make allowance for loss during the experiment)
Step 2: Enter in vivo formulation (This is only a calculator, not the exact formulation for a specific product. Please contact us first if there is no in vivo formulation in the solubility section.)
+
+
+

Calculation results

Working concentration mg/mL;

Method for preparing DMSO stock solution mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation:Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.

(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
             (2) Be sure to add the solvent(s) in order.

Biological Data
  • BMS-536924

    BMS-536924 inhibits IGF-IR signaling in pBabe-MCF10A cells and inhibits phosphorylation of CD8-IGF-IR. Clin Cancer Res. 2009 Jan 1;15(1):226-37.

  • BMS-536924

    BMS-536924 inhibits transformation in vitro and in vivo. Clin Cancer Res. 2009 Jan 1;15(1):226-37.

  • BMS-536924

    BMS-536924 decreases proliferation and cell number in MCF7 and MDAMB-435 acini and reverses MCF7 acini formation. Clin Cancer Res. 2009 Jan 1;15(1):226-37.

Contact Us